What does Brain+ A/S do?

Brain+ A/S (BRAINP.CO) operates in the Medical - Healthcare Information Services industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is BRAINP.CO's market cap?

Brain+ A/S (BRAINP.CO) has a market capitalization of approximately $4.8 million, as of March 19, 2026, based on the most recent share price and shares outstanding.

Does BRAINP.CO pay a dividend?

No — Brain+ A/S (BRAINP.CO) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

BRAINP.CO (Brain+ A/S) is no longer actively trading.

This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

BRAINP.CO

Brain+ A/S

CPH·Medical, Healthcare Information Services · Healthcare

kr 0.00kr 0.00+0.00%

Market capkr 4.76M·Market closed·Mar 19 11:37 AM UTC

Price Chart

kr 0.00+kr 0.00 (+0.00%)today

−99.90%CAGR −76.60%

Select date range

FromTo

Oct 7, 2021Oct 7, 2021 → Jul 22, 2026· 4.8 yrsJul 22, 2026

Key Metrics

BRAINP.CO does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateMay 22

Last Report DateJun 30

Reported vs Estimate−kr 0.02

Earnings Surprise—

FinancialsFinancials Tab

Revenuekr 2.17M

Net Income−kr 33.09M

Net Margin−1,526.7%

Operating Cash Flow−kr 33.99M

Capital Expenditureskr 5.57M

Free Cash Flow−kr 39.56M

Return on Equity−229.0%

Return on Invested Capital−24.3%

Net Cashkr 4.34M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for BRAINP.CO and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how BRAINP.CO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for BRAINP.CO and 80,000+ other tickers.

About Brain+ A/S

Brain+ A/S specializes in developing digital therapeutic solutions for individuals coping with Alzheimer's and various types of dementia. The company's portfolio includes Cognitive Stimulation Therapy (CST), which targets the primary symptoms of dementia, and Computerized Cognitive Training, a method designed for patients experiencing mild cognitive impairment. Additionally, Brain+ offers "Starry Night," a memory assessment tool crucial for the early detection and continuous monitoring of Alzheimer's disease. The firm also provides an intuitive interface that enables clinicians to effectively…

CEO: Devika Wood
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Exchange: CPH
Employees: 20
Website: www.brain-plus.com

Latest News

News Tab

No recent news available.

Frequently Asked Questions About BRAINP.CO

What does Brain+ A/S do?: Brain+ A/S (BRAINP.CO) operates in the Medical - Healthcare Information Services industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is BRAINP.CO's market cap?: Brain+ A/S (BRAINP.CO) has a market capitalization of approximately $4.8 million, as of March 19, 2026, based on the most recent share price and shares outstanding.
Does BRAINP.CO pay a dividend?: No — Brain+ A/S (BRAINP.CO) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.